|
Volumn 17, Issue 9, 2011, Pages 1755-1756
|
Escherichia coli O104:H4 from 2011 European outbreak and strain from south Korea
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
CEFOTAXIME;
CEFTRIAXONE;
COTRIMOXAZOLE;
NALIDIXIC ACID;
SULTAMICILLIN;
TETRACYCLINE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL GENE;
BACTERIAL STRAIN;
BACTERIUM ISOLATION;
ENTEROHEMORRHAGIC ESCHERICHIA COLI;
EPIDEMIC;
ESCHERICHIA COLI INFECTION;
EUROPE;
HEMOLYTIC UREMIC SYNDROME;
LETTER;
NONHUMAN;
PULSED FIELD GEL ELECTROPHORESIS;
SEROTYPE;
SHIGA TOXIN PRODUCING ESCHERICHIA COLI;
SHIGA TOXIN PRODUCING ESCHERICHIA COLI O104:H4;
SOUTH KOREA;
STRAIN DIFFERENCE;
STRAIN IDENTIFICATION;
STX 1 GENE;
STX 2 GENE;
ANTI-BACTERIAL AGENTS;
DISEASE OUTBREAKS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
EUROPE;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
REPUBLIC OF KOREA;
SHIGA TOXIN 1;
SHIGA TOXIN 2;
SHIGA-TOXIGENIC ESCHERICHIA COLI;
|
EID: 80052181592
PISSN: 10806040
EISSN: 10806059
Source Type: Journal
DOI: 10.3201/eid1709.110879 Document Type: Letter |
Times cited : (18)
|
References (6)
|